New pill tested to slow scarring lung disease
Disease control
Completed
This study tested a new oral medicine called INS018_055 in adults with idiopathic pulmonary fibrosis (IPF), a serious lung scarring disease. For 12 weeks, researchers compared the drug to a placebo pill in 71 participants to see if it was safe and if it could help slow the declin…
Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC